# Zhanguo Li

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zhanguo-li/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,102 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 55 |
| i10-index | 252 |
| Last Known Institution | China Pharmaceutical University |
| OpenAlex ID | https://openalex.org/A5039342892 |
| ORCID iD | https://orcid.org/0000-0002-2590-6242 |
| Works | 653 |

## Researcher papers

- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-2/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-3/)
- [Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis](https://scholariq.org/papers/tofacitinib-in-combination-with-nonbiologic-disease-modifying-antirheumatic/)
- [Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/efficacy-and-safety-of-low-dose-il-2-in-the-treatment-of-systemic-lupus/)
- [2018 update of the APLAR recommendations for treatment of rheumatoid arthritis](https://scholariq.org/papers/2018-update-of-the-aplar-recommendations-for-treatment-of-rheumatoid-arthritis/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

## Researcher university

- [China Pharmaceutical University](https://scholariq.org/institutions/china-pharmaceutical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.